HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Matthew Gagne Selected Research

Matthew Gagne Research Topics

Disease

15Infections
05/2024 - 01/2019
7COVID-19
11/2023 - 04/2021
5Virus Diseases (Viral Diseases)
01/2024 - 01/2021
5Inflammation (Inflammations)
01/2023 - 05/2021

Drug/Important Bio-Agent (IBA)

12VaccinesIBA
05/2024 - 01/2021
52019-nCoV Vaccine mRNA-1273IBA
05/2024 - 04/2021
4Antiviral Agents (Antivirals)IBA
01/2024 - 10/2022
4Neutralizing AntibodiesIBA
10/2022 - 05/2021
3Viral AntigensIBA
01/2023 - 05/2021
2Interferon Type IIBA
01/2023 - 10/2022
2InflammasomesIBA
01/2023 - 10/2022
2sortase AIBA
10/2022 - 02/2022
2Ferritins (Ferritin)IBA
10/2022 - 02/2022
2Proteins (Proteins, Gene)FDA Link
03/2021 - 01/2021
1Broadly Neutralizing AntibodiesIBA
05/2024
1COVID-19 VaccinesIBA
05/2024
1DNA (Deoxyribonucleic Acid)IBA
01/2024
1Messenger RNA (mRNA)IBA
11/2023
1AerosolsIBA
11/2023
1mRNA VaccinesIBA
11/2023
1CytokinesIBA
10/2022
1ChemokinesIBA
10/2022
1Sialic Acid Binding Ig-like Lectin 1IBA
10/2022
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2019
1LigandsIBA
01/2019
1Chimeric Antigen ReceptorsIBA
01/2019

Therapy/Procedure

2Therapeutics
01/2023 - 01/2023
2Euthanasia (Mercy Killing)
01/2023 - 01/2023